Bedwetting May Improve After Adenotonsillectomy for Sleep Apnea
Findings seen in secondary analysis of data for children randomly assigned to adenotonsillectomy or watchful waiting for nonsevere OSA
Sleep Disorders
Recall of Philips Breathing Machines Affects Millions of Americans
About 2 million of the recalled machines were in use in the United States
Xywav Approved for Idiopathic Hypersomnia
The approval was based on data from a phase 3 study that assessed Xywav in adults with idiopathic hypersomnia.
Obstructive Sleep Apnea May Raise Risk for Sudden Death
Meta-analysis shows sleep apnea linked to increased risk for sudden death, cardiovascular mortality
Oral Orexin Agonist Gets Breakthrough Therapy Status for Narcolepsy Type 1
The Company is currently investigating TAK-994 in adults with narcolepsy type 1 or type 2 in a phase 2 study.
AHA Advises OSA Screening for Those With CV Risk, Conditions
Screening for obstructive sleep apnea recommended for those with resistant/poorly controlled HTN, pulmonary HTN, recurrent a-fib
Sleep Medications Do Not Improve Sleep Disturbance in Women
Women who initiated sleep medications rated their sleep disturbances similarly after 1 and 2 years.
Xywav Gets Priority Review for Idiopathic Hypersomnia
The sNDA is supported by data from a phase 3 study that assessed Xywav in adults with idiopathic hypersomnia.
FDA to Review Daridorexant for Insomnia Treatment
The FDA has accepted for review the NDA for daridorexant, an investigational dual orexin receptor, for the treatment of insomnia in adults.
FDA to Review Once-Nightly Sodium Oxybate Formulation for Narcolepsy
The NDA submission is supported by data from the phase 3 REST-ON study.
